Intelligent Bio Solutions Inc. (INBS)

USD 1.21

(0.83%)

Total Liabilities Summary of Intelligent Bio Solutions Inc.

  • Intelligent Bio Solutions Inc.'s latest annual total liabilities in 2024 was 5.59 Million USD , down -16.08% from previous year.
  • Intelligent Bio Solutions Inc.'s latest quarterly total liabilities in 2024 FY was 5.59 Million USD , down -16.08% from previous quarter.
  • Intelligent Bio Solutions Inc. reported annual total liabilities of 6.66 Million USD in 2023, up 14.83% from previous year.
  • Intelligent Bio Solutions Inc. reported annual total liabilities of 5.8 Million USD in 2022, down -15.27% from previous year.
  • Intelligent Bio Solutions Inc. reported quarterly total liabilities of 6.04 Million USD for 2024 Q3, up 6.49% from previous quarter.
  • Intelligent Bio Solutions Inc. reported quarterly total liabilities of 5.59 Million USD for 2024 FY, down -16.08% from previous quarter.

Annual Total Liabilities Chart of Intelligent Bio Solutions Inc. (2024 - 2017)

Historical Annual Total Liabilities of Intelligent Bio Solutions Inc. (2024 - 2017)

Year Total Liabilities Total Liabilities Growth
2024 5.59 Million USD -16.08%
2023 6.66 Million USD 14.83%
2022 5.8 Million USD -15.27%
2021 6.85 Million USD -10.89%
2020 7.69 Million USD 21.97%
2019 6.3 Million USD 13.41%
2018 5.55 Million USD -15.5%
2017 6.57 Million USD 0.0%

Peer Total Liabilities Comparison of Intelligent Bio Solutions Inc.

Name Total Liabilities Total Liabilities Difference
Aclaris Therapeutics, Inc. 40.22 Million USD 86.089%
Applied DNA Sciences, Inc. 8.77 Million USD 36.262%
Aspira Women's Health Inc. 8.62 Million USD 35.138%
Biodesix, Inc. 94.51 Million USD 94.08%
BioNexus Gene Lab Corp. 1.74 Million USD -221.232%
bioAffinity Technologies, Inc. 3.36 Million USD -66.226%
bioAffinity Technologies, Inc. 3.36 Million USD -66.226%
Bionano Genomics, Inc. 118.24 Million USD 95.268%
CareDx, Inc 223.28 Million USD 97.494%
Check-Cap Ltd. 1.33 Million USD -320.727%
Castle Biosciences, Inc. 86.54 Million USD 93.534%
DarioHealth Corp. 38.24 Million USD 85.369%
Exact Sciences Corporation 3.32 Billion USD 99.832%
Fulgent Genetics, Inc. 139.82 Million USD 95.998%
Guardant Health, Inc. 1.62 Billion USD 99.656%
ICON Public Limited Company 7.74 Billion USD 99.928%
IDEXX Laboratories, Inc. 1.77 Billion USD 99.685%
Illumina, Inc. 4.36 Billion USD 99.872%
iSpecimen Inc. 6.07 Million USD 7.937%
Standard BioTools Inc. 159.86 Million USD 96.5%
MDxHealth SA 121.92 Million USD 95.411%
23andMe Holding Co. 206.64 Million USD 97.292%
Medpace Holdings, Inc. 1.09 Billion USD 99.49%
Myriad Genetics, Inc. 312.9 Million USD 98.212%
Mainz Biomed B.V. 12.15 Million USD 53.982%
ENDRA Life Sciences Inc. 1.09 Million USD -410.947%
NeoGenomics, Inc. 739.69 Million USD 99.244%
Neogen Corporation 1.44 Billion USD 99.611%
Inotiv, Inc. 588.04 Million USD 99.048%
Natera, Inc. 691.79 Million USD 99.191%
OpGen, Inc. 13.44 Million USD 58.377%
OPKO Health, Inc. 622.47 Million USD 99.101%
Psychemedics Corporation 6.59 Million USD 15.191%
Prenetics Global Limited 44.01 Million USD 87.286%
Prenetics Global Limited 44.01 Million USD 87.286%
Precipio, Inc. 3.67 Million USD -52.388%
Personalis, Inc. 95.65 Million USD 94.15%
RadNet, Inc. 2.07 Billion USD 99.73%
Sera Prognostics, Inc. 25.28 Million USD 77.868%
Sotera Health Company 2.68 Billion USD 99.792%
Neuronetics, Inc. 81.64 Million USD 93.146%
Star Equity Holdings, Inc. 21.67 Million USD 74.184%
Star Equity Holdings, Inc. 21.67 Million USD 74.184%
Trinity Biotech plc 83.38 Million USD 93.289%
T2 Biosystems, Inc. 62.83 Million USD 91.094%
Twist Bioscience Corporation 152.97 Million USD 96.342%
Exagen Inc. 34.25 Million USD 83.662%